The rising incidence rate of chronic diseases and the increasing number of geriatric population have resulted in boosting the Infusion Therapy market.
The Global Infusion therapy market is forecast to reach USD 10.98 Billion by 2027, according to a new report by Reports and Data. Infusion therapy is used to give antibiotics, and life-saving hydration fluids that are administered with the help of IV to care users. In this therapy, the medication is administered with the help of a catheter or a needle. Care providers recommend this therapy when the condition of the patient is severe, unable to swallow, or drug recommended is a biologic response. It is commonly used in hospitals; however, in the present healthcare scenario, it can be administered in outpatient infusion therapy centers or even at home care with the assistance of specially trained nurses. The therapy is usually employed for treating chronic infections or serious conditions when patients do not respond to oral antibiotics. Various initiatives of market players like, acquisition are also supporting the market growth. As an instance, in 2016, ICU Medical Inc. was supposed to acquire Pfizer Inc’s Hospira Infusion Systems Business for USD 1.00 Billion. Such initiatives by market players, along with strengthening their market position, are also propelling the market growth. In regards to the region, Europe is projected to occupy a considerable share of the market. The market share held by the region is attributed to the continuously expanding healthcare sector and rising geriatric population.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2601
Further key findings from the report suggest
- The Infusion therapy market held a market share of USD 7.61 Billion in the year 2018 that is forecasted to grow at a rate of 4.1% during the forecast period.
- In context to Product Type, the Infusion pumps held the largest market share of more than 30.0% in 2018, with a CAGR of 4.2% during the forecast period. The market share held by this segment is attributed to its extensive application in the healthcare sector due to the advantage of delivering fluids in small as well as large amount and applicability in delivering medications like hormones, antibiotics, chemotherapy drugs, and nutrients.
- In context to Therapy Type, the Nutritional therapy segment held the largest market share of 23.0% in 2018, with a significant growth rate of 4.2% during the forecast period. The fact this therapy is most commonly and extensively used in treating dehydration with the help of an intravenous drip in the healthcare sector contributes to the market share held by this segment.
- In regards to End-user, the Hospital segment held the largest market share of 49.0% in 2018, with a CAGR of 4.2% during the forecast period. The market share held by the segment is attributed to the increasing demand for cardiovascular treatment and chemotherapy from this care providing organizations.
Regional Outlook:
North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions. Due to favorable regulations and policies in these regions, healthcare industry is rapidly growing. As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.
Order this Report @ https://www.reportsanddata.com/report-pricing/2601
Competitive Outlook:
The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry. Market-trend-based strategies for the healthcare market include increasing the adoption of bundled payments, using digital tools, increasing collaborations across industries and companies, focusing on the development of new medicines, and adopting hybrid imaging technology. Players adopted strategies in the healthcare industry include acquiring companies in similar industries to expand their presence and focusing on offering quality products and services.
The competitive landscape section of the report discusses in detail the company overview, product and services portfolio, business expansion plans, production and manufacturing capacity, financial standing, and global market position. It further sheds light on the recent mergers and acquisitions, collaborations, partnerships, corporate and government deals, agreements, and product launches.
Top companies operating in the market and profiled in the report include:
GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc. Allergan, Plc., AbbVie Inc., Fresenius SE & Co. KGaA, B. Braun Melsungen AG., Takeda Pharmaceutical Company Limited., Baxter International Inc., Shire Plc and BioScrip.
Further, the report segments the Infusion Therapy market on the basis of product types, applications, end-use industries, and technology among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.
Infusion Therapy Market Segmentation:
Disease Type Outlook (Revenue, USD Billion; 2016-2027)
- Cardiovascular diseases
- Cancer
- Infectious disease
- Diabetes
- Nephrology & urological disorder
- Inflammatory diseases
- Pain management
- Immune deficiency disorders
- Others
Therapy Type Outlook (Revenue, USD Billion; 2016-2027)
- Inotropic therapy
- Antibiotic & viral infusion therapy
- Chemotherapy
- Anti-coagulation infusion therapy
- Anesthesia
- Nutritional therapy
- Blood and blood component infusion therapy
- Others
Product Type Outlook (Revenue, USD Billion; 2016-2027)
- Intravenous sets
- Infusion pumps
- Needleless connectors
- IV cannulas
- Vein imaging devices
- Others
End-user Outlook (Revenue, USD Billion; 2016-2027)
- Hospital
- Clinics
- Ambulatory surgery centers
- Home care
- Others
Regional Analysis covers:
- North America
- US.
- Canada
- Mexico
- Europe
- Germany
- Italy
- UK.
- Rest of EU
- Asia Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- A.E
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2601
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized to meet your requirements.
Browse More Reports:
Temporary Pacemaker Market @ https://www.biospace.com/article/temporary-pacemaker-market-size-share-trends-growth-industry-analysis-company-profiles-and-forecast-by-2028/
Peripheral Artery Disease (PAD) Medical Device Market @ https://www.biospace.com/article/peripheral-artery-disease-pad-medical-device-market-size-share-industry-growth-trend-drivers-challenges-key-companies-by-2028/
Histoplasmosis Treatment Market @ https://www.biospace.com/article/histoplasmosis-treatment-market-trends-revenue-key-players-growth-share-and-forecast-till-2028/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full press Relaease @ https://www.reportsanddata.com/press-release/global-infusion-therapy-market
